What a sad day for mRNA!
Aussie17
Well, well, well… look who’s quietly closing the doors on their shiny new mRNA empire.
Remember
when Singapore was going to be the gleaming hub of the “mRNA
revolution” in Asia? Yeah, that dream just got quietly euthanised.
BioNTech,
the same German outfit that partnered with Pfizer to push the
experimental genetic shots we were all forced to take, has announced it
is shutting down its flagship Singapore vaccine production plant by early 2027.

This was their biggest mRNA manufacturing bet in Asia.
Acquired in 2022 from Novartis in Tuas Biomedical Park, it was supposed
to be their Asia-Pacific regional headquarters. Fully built-out,
state-of-the-art, ready to churn out several hundred million doses of mRNA vaccines per year.
They hyped it hard. Singapore’s Economic Development Board cheered. Jobs were promised. The future was bright. The jab was going to “save the world” and make them billions.
Fast forward four years.
The plant is being closed.
The workers are being shown the door.
The reason? Massive, catastrophic collapse in COVID-19 vaccine sales.
No
more boosters. No more demand. Lots of damaged heart. 300% increase in
ALS Drug sales on a post vaccinated population. The public finally got
the message that the “Safe and Effective™” miracle was nothing but a
snake oil scam.
And just in case you thought this was some isolated Singapore problem… think again.
This week, Pfizer and BioNTech quietly halted a massive U.S. clinical trial
for their updated COVID-19 vaccine targeting healthy adults aged 50 to
64. The study, which aimed to recruit 25,000 to 30,000 participants, was
shut down because they simply couldn’t get enough people to sign up.
Recruitment
struggles? That’s putting it mildly. Over 80% of people who showed even
slight interest failed pre-screening. The companies admitted they
couldn’t generate the “relevant post-marketing data” they needed. No
safety issues, they claim, just nobody showing up for another round of
the jab even if you’re paying them.

This
isn’t some small side study. It was meant to support approval and
recommendations for a huge chunk of the adult population. Now? No data
for the upcoming FDA advisory meeting. No clear path forward for this
age group. The mRNA machine is literally running out of willing guinea
pigs.
Just like the ALS drug sales spiking 300% and the stroke drug sales jumping 200% that I showed you in Part1 and Part 2,
the data from Singapore never lies. High vax rates, excellent tracking,
perfect little petri dish for spotting what the jab is really doing
long-term.
And now even BioNTech itself is admitting, in the coldest possible way, that the party is over, both in the factory and in the clinic.
The
mRNA cash cow that made them tens of billions during the pandemic has
dried up. The “excess capacity” they built in Singapore is now… well…
excess. Because nobody in their right mind wants another shot of
whatever that DNA Contaminated stuff actually was.

Aussie17·20 September 2025vRead full story
Singapore,
the same country that ranked #1 in the world for excess deaths while
boasting 92%+ vaccination rates, now watches another pillar of the mRNA
fantasy quietly fold.
The jab that keeps on giving… just keeps on taking.
Taking lives.
Taking jobs.
Taking manufacturing plants.
Taking the last scraps of credibility from the entire “this is the future of medicine” narrative.
What a triumph!